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CHAPTER I 
INTRODUCTION 
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Over the past several years, many published studies have provided evidence that 
consumption of green tea (GT), green tea extract (GTE), or epigallocatechin gallate 
(EGCG, the main component of GT) can result in weight loss, increased fat oxidation, 
and elevated energy expenditure (EE) in mice and humans both at rest and while 
exercising (1-8). Meta-analyses and review articles have also confirmed these results (9-
12). Furthermore, consumption of GTE has been shown to result in increased exercise 
endurance in mice (4, 13, 14) and improved maximal oxygen uptake (VO2max) in humans 
(15). These findings suggest that consumption of GT or GTE might improve exercise 
endurance in humans, possibly by increasing fat oxidation (4). In contrast, a recent a 
study by Dean et al. (16) found no significant increase in exercise endurance in cyclists 
consuming EGCG. However, they only examined the effect of short-term (6 days), 
moderate dose (270 mg) supplementation of caffeine-free EGCG. The objective of this 
study was to determine if the daily consumption of decaffeinated GTE, for 4-5 weeks, 
could improve exercise endurance in humans, as measured by 2.5 mile running time trials 
conducted on an indoor track. 
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CHAPTER II 
REVIEW OF LITERATURE 
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Background 
GT, one of the most consumed beverages in the world (17, 18), has received a 
great deal of attention in the last few decades as a potential enhancer of health. Research 
has suggested that consumption of GT could promote weight loss (2, 3, 8, 19-22); protect 
against cardiovascular disease (2, 10, 23-25) and cancer (26-31); scavenge free radicals 
more effectively than vitamins C and E (32, 33); reduce insulin resistance in diabetics (5, 
7); combat the HIV virus (34, 35); protect against neurodegenerative diseases such 
Alzheimer Disease and Parkinson Disease (36); and reduce all of the risk factors related 
to metabolic syndrome (a condition that refers to a group of cardiometabolic risk factors 
that usually includes dyslipidemia, central obesity, hyperglycemia, and hypertension) (21, 
37). These health benefits associated with GT consumption are attributed to a class of 
polyphenols known as catechins (10, 18, 33, 38). Catechins present in GT include EGCG, 
epicatechin gallate, gallocatechin, and epigallocatechin. EGCG has received the most 
attention, as it is considered to be the most potent and biologically active catechin in GT 
(3, 38-40).  
While some of the catechins found in GT are also found in small amounts in 
chocolate, some fruits and vegetables, some nuts, and carob flour, GT contains the 
highest amounts of them per typical serving size (41). Black tea also contains some of 
these same catechins, but has significantly less than GT because the fermentation process 
used to make black tea changes the chemical structure of the polyphenols found in the tea 
leaf (42).  
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The exact amount of catechins in GT varies greatly depending on where and how 
it is grown and harvested, how long and in which manner it is stored, and how much of it 
and by which methods it is prepared (10, 43). Estimates range from ~100-250 mg of total 
catechins (43) and ~26-226 mg EGCG per cup of tea. It is also estimated that the median 
amount of EGCG per cup of GT is ~ 150 mg (15). Those estimates are fairly consistent 
with the amounts of GT catechins measured by the USDA. Their “Flavonoid Database” 
lists an estimated average amount of ~125 mg of catechins and ~77 mg of EGCG per 1 g 
of GT leaves infused in water (41). The 1.5 -2.0 g of dry tea contained in many tea bags 
and recommended for use by distributors of loose leaf tea (44) would result in, based on 
USDA data, 187-250 mg of total catechins and 116-155 mg of EGCG in a cup of tea. 
Also, new extraction methods have recorded levels of catechins in GT higher than 
previously measured (45), suggesting there could be more total catechins in GT than 
previously thought. Although the exact amount of total catechins and EGCG in a 
“typical” cup of tea is difficult to estimate, based on the above research, it would be 
reasonable to expect an average cup of tea to contain approximately 90-170 mg EGCG 
and 150-250 mg total catechins.  
 
The effect of GT on weight loss, fat oxidation, and EE in mice and humans 
In 1999, Dulloo et al. (3) conducted one of the earliest studies that examined the 
potential of GT consumption to increase EE and fat oxidation. In this double-blind, 
crossover study design, participants spent three separate 24-hr trials in a respiratory 
chamber. During each trial, the participants consumed 2 capsules with each of their 3 
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meals (6 capsules per trial). The 6 capsules contained, in total, one of the following: (1) 
GTE, containing 375 mg catechins (270 mg EGCG) and 150 mg caffeine; (2) 150 mg 
caffeine only; or (3) placebo (inert cellulose). The order of the trials for each subject was 
randomly assigned. During the 24-hour period spent in the respiratory chamber, 
participants’ diet, activity pattern (sedentary), meal pattern, and sleeping habits were the 
same. Results showed that, relative to caffeine and placebo, consumption of GTE 
significantly increased EE  (P < 0.01), and lowered the respiratory quotient (RQ) (P < 
0.001), indicating increased fat oxidation. Treatment with caffeine equal to that contained 
in the GTE had no significant effect on either measurement.  
This study had some strengths. It was well controlled as participants were 
confined to a laboratory setting with activity levels and diet strictly matched. Also, 
researchers not only compared GT to placebo, but also compared it directly with an equal 
amount of caffeine. Because of this design, the results of this study strongly suggest that 
the increased EE and fat oxidation elicited in the subjects consuming GTE were due, in 
large part, to the effects of the catechins in the GTE, and not primarily due to its caffeine 
content or variations in the participants’ diets or activity levels.  
Several studies conducted on mice published over the past decade found results 
similar to that of Dulloo et al. (3). These studies showed that consumption of GTE 
resulted in significant reductions in body weight, abdominal fat mass, cholesterol, and 
serum triacylglycerols in mice fed both normal and high fat (HF) diets (46-48). A 2008 
study (49) looked at the effect of EGCG on mice fed a HF diet.  Compared with control 
mice fed a HF diet, mice that consumed EGCG while on a HF diet (HFE) had 
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significantly less body weight gain (33-41% less), lower percent body fat, and lower 
visceral fat weight (37% less) after long term (16 week) EGCG supplementation (P < 
0.05 for all measures).  Mice fed the HFE diet also had significantly (P < 0.05) lower 
blood glucose (25% decrease), plasma insulin (61% reduction), plasma cholesterol, liver 
weight, liver triacylglycerols, and plasma alanine aminotransferase concentrations (a 
marker of liver damage and predictor of nonalcoholic fatty liver disease) compared with 
mice fed the control HF diet (49, 50).  
This study had many strengths. It examined the effects of EGCG alone, thus 
removing the potential for caffeine to affect the results. It controlled for and examined a 
number of markers that reflect fat metabolism. Furthermore, compared with some 
previous animal studies, the amount of EGCG given to the mice was lower (3.2 g/kg food 
intake) and thus more relevant to humans (49). Relative to their food intake, mice 
consumed the amount of EGCG equivalent to a human on a 2,000 kcal diet consuming 8-
10 cups of green tea per day, which is considered a safe amount (51-53). The authors 
suggested that the reductions in body weight, fat gain, and insulin resistance found in 
mice supplemented with EGCG were likely due to decreased fat absorption, anti-
inflammatory effects, decreased fatty acid synthesis, and increased fatty acid oxidation 
(49). The results of these mice studies reinforced the earlier findings of Dulloo et al. (3) 
that consumption of GT can induce thermogenesis and increase fat oxidation. 
In 2009, Thielecke and Boschmann (37) reviewed the effects of short- and long-
term consumption of GT on metabolic syndrome in humans. The authors reviewed 12 
human studies on the effects of GT consumption on weight loss and 9 studies on GT 
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consumption and its effects on EE and fat oxidation. The majority of these studies 
showed significant decreases in weight and fat mass, and increases in EE and fat 
oxidation for GT treatment vs. placebo (P < 0.05). Studies showed body weight 
reductions ranging from 0.7 kg to 3.5 kg, and body fat reductions ranging from 0.7 kg to 
1.8 kg in GT groups. GT had a significant effect on body weight and body fat reduction 
in studies where subjects consumed a moderate energy-restricted diet as well as in those 
studies where subjects consumed a normal diet.  
A 2009 meta-analysis (12) examined the effects of GT on weight loss (WL) and 
weight maintenance (WM).  These researchers controlled for high habitual caffeine 
intake and ethnicity. GT studies on Asian populations and those with low habitual 
caffeine intake have found a greater effect of GT on WL than studies on non-Hispanic 
white populations and those on habitually high caffeine users. Eleven WL or WM studies 
met their inclusion criteria of being randomized, with blinded participants, using a GT or 
GTE intervention compared with placebo, and a length of 12 weeks. Their analysis 
revealed that GT plus caffeine significantly reduced or maintained BW when compared 
with placebo (P < 0.001). While neither the amount of habitual caffeine intake nor 
ethnicity individually affected WL or WM significantly (P > 0.05), the interaction of 
ethnicity and caffeine intake was a significant moderator (P = 0.04) 
In a recent systematic review and meta-analysis, Phung et al. (11) analyzed 
randomized control trials looking at the relationship between GT or GTE consumption 
and anthropometric measures such as body mass index (BMI), body weight, waist 
circumference (WC), and waist-to-hip ratio (WHR). Fifteen studies met inclusion criteria 
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and were divided into 3 separate groups: six studies that compared GT or GTE plus 
caffeine (GT+C) with a caffeine-matched control, five studies that compared GT+C with 
a caffeine-free control, and two that compared decaffeinated GTE (GT-C) with a 
caffeine-free control. Using a random-effects model, a weighted mean difference of 
change from baseline (with 95% Confidence Intervals [CIs]) was calculated for each 
group of studies. 
Results of the meta-analysis revealed the following: (1) GT+C showed 
statistically significant reductions in BMI, body weight, and WC compared with the 
caffeine only group; (2) GT+C significantly decreased body weight when compared with 
a caffeine-free control; (3) GT-C did not show any statistically significant changes in 
anthropomorphic measures compared with the caffeine-free placebo.  The significant 
results found in the pooled data of first two groups of studies support previous research 
that consumption of GT can promote weight and fat loss (however, the authors stated that 
the clinical significance is “modest”). The authors concluded that there might be a 
synergistic effect between catechins and caffeine in increasing energy expenditure and fat 
oxidation.  While the authors did not find any effect of decaffeinated GT alone on 
anthropomorphic measures, they only examined two studies that tested this, with one 
finding some significant effects on BMI and weight loss and the other not finding such 
effects. Their conclusions were in contrast to previous studies on mice discussed above 
that found a pronounced effect of decaffeinated GT or EGCG on body weight.  
Lastly, Thielecke et al. (6) published a study last month (April 2010, after the 
publication of the above meta-analyses) that found that short-term (3 days), consumption 
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of decaffeinated, “low” dose (300 mg) EGCG by obese men significantly increased (P < 
0.05) postprandial fat oxidation compared with placebo. This effect was equal to the 
effect of consumption of 200 mg caffeine. While EGCG did not significantly increase 
fasting fat oxidation over placebo, 200 mg caffeine did (by 26.3%, P < 0.05), and EGCG 
plus caffeine did so to an even greater extent (by 35.4%, P < 0.01 vs. placebo and EGCG 
alone). Both fasting and post-prandial RQ values were significantly lower for EGCG + 
caffeine when compared with placebo (P < 0.001). 
 
Mechanisms of action of GT consumption on weight loss 
 Several mechanisms have been proposed to explain why consumption of GT is 
linked to reductions in body fat, weight, and central adiposity. Firstly, EGCG receptors 
are found in most cells, which potentially explains the far-reaching effects of GT (39). 
GT has been proposed to reduce body fat by increasing fat oxidation, decreasing 
lipogenesis, and decreasing fat absorption (1, 5, 37, 39). It is proposed that GT increases 
fat oxidation by prolonging the action of norepinephrine, a catecholamine released by the 
sympathetic nervous system, through inhibition of catechol-O-methyl-transferase 
(COMT), an enzyme that degrades norepinephrine (3, 40). Elevated levels of 
norepinephrine increase hepatic fat oxidation and overall mobilization of lipids for 
oxidation from adipocytes throughout the body (1, 3, 39, 40).  
GT is further theorized to promote fat oxidation and weight loss through 
activation of thermogenesis in brown adipose tissue (3, 40). GT catechins have been 
shown to work synergistically with caffeine (a natural component of green tea) to 
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increase the respiration rates of brown adipose tissue in mice more than an equal amount 
of caffeine alone did. Combinations of ephedra, caffeine, and GT have also been shown 
to produce with weight loss in humans (3, 40). However, such weight loss did not appear 
to be occurring in humans via activation of brown adipose tissue because, until recently, 
it was thought that adult humans do not have any significant amounts of this thermogenic 
tissue.   
However, three recent studies (54-56) provided strong evidence that adult humans 
do contain significant stores of brown adipose tissue. It is now known that increased 
action of norepinephrine or being subjected to cold can activate brown adipose tissue in 
humans. Because GT has been shown to increase or prolong the action of norepinephrine 
(3, 13, 40), it is plausible that GT activates brown adipose tissue in humans as it does in 
mice. This could explain some of the positive results that have shown GT to be an aid in 
increasing energy expenditure, thermogenesis, and weight loss. 
Several reviews (9-11) have suggested other possible mechanisms though which 
GT consumption might aid in fat reduction, including decreasing energy intake and 
absorption (via reductions in appetite, food consumption, blood glucose, lipid 
emulsification, lipid digestion and absorption, lipid transport, and insulin concentrations). 
It is theorized that those actions result in positive effects on adipocytes such as increased 
apoptosis and lipolytic activity, and decreased growth, differentiation, lipogenic activity, 
and glucose intake. This can lead to increased energy expenditure via increased 
thermogenesis, fat oxidation, muscle cell glucose uptake (due to increased GLUT 4 
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activity), fecal lipid excretion, tumor necrosis factor α, and decreased hepatic liver 
production (39). 
 
The effects of GT consumption on exercise endurance in mice 
The early research demonstrating that the consumption of GT can increase fat 
oxidation in humans and rodents led some researchers to hypothesize that GT could 
potentially be a useful aid for increasing exercise endurance. This hypothesis was based 
on the fact that the ability to oxidize more fat during exercise is a likely advantage for 
endurance athletes (4, 13, 57). This is because glycogen stores are limited, and therefore 
the body will increasingly rely on fat for fuel as muscles become depleted of glycogen 
(58). In fact, one of the adaptations that occurs as a result of exercise is an increased 
ability to oxidize fat (57), which delays glycogen depletion. Furthermore, research has 
shown that muscles do not to have to be completely empty of glycogen in order for 
fatigue to occur (58, 59). It has been shown that reduced glycogen content in muscles will 
immediately result in athletes choosing a slower pace and easier effort when beginning a 
1 hour time trial (58). This may be due to the fact that any significant decrease in 
glycogen stores could signal the brain, possibly via feedback sent to the CNS from 
chemoreceptors in muscle, that exhaustion is near and therefore cause the brain to signal 
muscles to reduce their effort (58-60).   
Therefore, an ability to keep glycogen stores relatively high during exercise might 
delay the stress signals sent to the brain that result in decreased muscular effort (58) and 
increasing one’s use of fat for fuel could help one achieve that end. Also, increased use of 
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fatty acids for energy in place of glucose tends to be associated with lower lactate levels, 
which is associated with lower fatigue levels (4, 13). Renowned Italian distance running 
coach Renato Canova, who works closely with several of the best Kenyan distance 
runners, has written extensively on the importance of fat oxidation for endurance running 
(61).  
All of the aforementioned reasons explain why the ability to increase use of fat for 
energy, even during shorter endurance exercise events, which do not highly deplete 
glycogen stores, could be advantageous for delaying fatigue. Because GT has been shown 
to increase fat oxidation in mice and humans, the hypothesis that it might be able to 
increase exercise endurance was a natural next step to investigate.   
Murase et al. (4, 13) conducted two studies on mice that became the first to 
directly measure the effect of GTE on exercise endurance. In each study the researchers 
gave three groups of mice the same endurance training and the same diet for 8-10 weeks. 
One group received 0.2% GTE (wt/wt) in their diet, another group received 0.5% GTE, 
while the exercise-control (Ex-cont) group received no GTE.  These studies compared the 
effects of GTE and placebo on endurance capacity (running and swimming to 
exhaustion), energy metabolism, and fat oxidation. Mice given endurance training plus 
0.5% GTE improved endurance capacity by 24-30% more than Ex-cont mice. These 
findings were statistically significant (P < 0.05, P < 0.001). Mice given 0.2% GTE also 
increased their endurance capacity compared to Ex-cont mice in both studies, but the 
differences were not statistically significant.  
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These two studies also revealed that compared to Ex-cont mice, the mice fed 
0.5% GTE had significantly (P < 0.05 and P < 0.01) lower respiratory exchange ratios 
(RER’s) both at rest and during exercise, higher muscle β-oxidation, and higher 
concentrations of plasma non-esterified fatty acids (NEFA). Immediately after exercise, 
mice fed GTE also had significantly lower levels of plasma lactate and lower reductions 
in muscle glycogen content, the latter by an impressive 84%.  Furthermore, GTE mice 
had lower levels of muscle malonyl-CoA content. All of these measurements indicated an 
increased utilization of fat both at rest and during exercise. 
Murase et al. (13) found that EGCG consumption also significantly improved 
endurance in mice. This suggests that the endurance-enhancing effect of GT consumption 
is strongly mediated by EGCG. However, because the effects were not as pronounced as 
those found with GTE, EGCG is likely not the only component of GT that influences 
endurance and fat metabolism.  
In both of Murase et al.’s studies (4, 13), the GTE consumed by the mice 
contained a negligible amount of caffeine. In the second study (4) they state that their 
GTE “did not contain caffeine”. However, earlier in the article they state that it contained 
0.1% caffeine, the same amount as their first study. Furthermore, in their first study (13), 
consumption of decaffeinated EGCG elicited much of the same effects as did 
consumption of GTE. Therefore, the authors concluded that it was the catechins present 
in GT, not the caffeine, that produced the significant effects on measured endurance and 
fat metabolism.  
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Other studies looking at the effects of GT on physical capacity and endurance in 
mice observed similar physiological improvements with GT consumption (38, 47, 48). 
The findings from these studies suggest that GT consumption increases whole body lipid 
utilization and decreases carbohydrate use during exercise. As discussed above and 
demonstrated in the time to exhaustion results, such actions appear to be advantageous 
for delaying fatigue during endurance exercise (4, 13). 
 
The effects of GT consumption on fat oxidation in exercising humans  
With GT/GTE consumption having been shown to increase fat oxidation in 
humans and mice at rest and to improve endurance and fat oxidation in exercising mice, 
the next step was to determine if GT could enhance fat oxidation in humans during 
exercise. Two recent studies demonstrated just this (1, 5). Venables et al. (5) found that 
the acute (24 hr.) consumption of decaffeinated GTE significantly (P < 0.01) increased 
fat oxidation in human subjects during a single moderate exercise bout (workload = 60% 
VO2max; average HR 135 bpm). Subjects oxidized 17% more fat during exercise after 
consuming GTE (3 capsules in 24 hours containing a total of ~ 900 mg polyphenols and 
370 mg EGCG) than they did after consuming placebo (5).  
A randomized, double-blind design by Maki et al. (1) also demonstrated that GT 
consumption might increase fat oxidation in exercising humans.  Obese participants who 
completed a 12-week protocol of exercise and daily consumption of a GTE beverage 
(containing 625 mg GT catechins, including 215 mg EGCG) had significantly higher 
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decreases in total abdominal fat area (P = 0.013) and subcutaneous abdominal fat area (P 
= 0.019) compared with obese subjects who only exercised during this period (1).  
Both the Venables et al. (5) and Maki et al. (1) studies showed that GT 
consumption appears to enhance the fat oxidation effects of exercise in humans. Venables 
et al.(5) showed this effect using a very short term (24 hrs), moderate dose 
supplementation of decaffeinated GTE (= ~ 3-4 cups GT per day), while Maki et al. did 
so using a longer term (12 weeks), low dose supplementation of a GTE beverage (= ~ 2 
cups GT/d) containing a small amount of caffeine. Taken together, these two studies 
strongly suggest that acute or regular consumption of low to moderate doses of GT 
catechins, containing no or little caffeine, can result in increased fat oxidation in 
exercising humans.  
 
Mechanisms of action of GT consumption on increased fat oxidation during exercise 
Although the exact mechanisms through which GT consumption increases lipid 
usage during exercise is not fully understood, they appear to be similar to those 
mechanisms by which GT promotes weight loss. First, GT decreases the malonyl-CoA 
content of muscles, which results in increased plasma fatty acid (FA) concentrations in 
the blood (4). If such an increase occurs during exercise, the body may adapt to the 
increased FA exposure by utilizing greater amounts of lipids (4, 47). Second, GT inhibits 
COMT, an enzyme that degrades norepinephrine, a catecholamine produced by the 
sympathetic nervous system, which becomes very active during stressful situations such 
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as exercise. Norepinephrine is released to augment physiologic functions necessary to 
survive, or more efficiently handle, such stress (3, 4, 62). 
Norepinephrine interacts with a series of adrenergic receptors (α- 1 and 2, and β- 
1, 2, and 3)  in order to induce its effects. Stimulation of these receptors triggers synthesis 
of cyclic adenosine monophosphate (cAMP), a secondary messenger, which in turn 
activates protein kinase A (PKA) resulting in increased action by hormone sensitive 
lipase (62). This metabolic cascade amplifies various physiologic functions including 
heart rate, peripheral blood flow, glycogenolysis, glucose production, and lipolysis in 
adipocytes.  All of these actions are potentially beneficial during exercise. By stimulating 
lipolysis in fat cells, the pool of available FA’s that can be used for fuel is increased. 
Furthermore, catecholamines such as norepinephrine directly increase fatty acid 
availability in skeletal muscle by increasing the breakdown of triacylglycerols via 
hydrolysis, an action controlled by PKA stimulation of hormone sensitive lipase. Because 
hormone sensitive lipase is already activated in muscle during exercise, GT consumption 
might heighten muscle triacylglycerol breakdown during exercise via prolonging the 
action of norepinephrine (62).  
 
The effects of GT consumption on exercise endurance in humans 
With evidence that consumption of GT enhances fat oxidation in humans both at 
rest and during exercise, and exercise endurance in mice, researchers next tested whether 
consumption of GT could improve exercise endurance in humans. In a randomized 
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double-blind study, Richards et al. (15) demonstrated that very short term consumption of 
EGCG (405 mg/d for 2 d, and 135 mg taken 2 hrs before exercise test) significantly (P= 
0.04) increased maximal oxygen uptake (VO2max) in healthy adults engaged in stationary 
cycling exercise. VO2max (maximal cardiac output x maximal arterial-venous oxygen 
difference) is considered an important measurement or predictor of an individual’s 
potential aerobic or endurance exercise ability (15). Because this study did not 
demonstrate an increase in the participants’ maximal cardiac output, the authors 
concluded that EGCG was likely exerting its effects on VO2max by increasing the 
maximal arterial-venous oxygen difference.  
The authors suggested that this could occur through the antioxidant properties of 
ECGC, an augmentation of the metabolic response to β-adrenergic receptor stimulation 
(which occurs during exercise) or the uncoupling of electron transport from ATP 
synthesis. The authors speculated the last possibility because research has shown that 
EGCG consumption can increase uncoupling protein-2 gene expression in 3T3-L1 fat 
cells. Thus, it is thought that the increased energy expenditure and lipid oxidation found 
in humans consuming EGCG might be due to the uncoupling of electron transport from 
ATP synthesis (15).  
 The Richards et al. (15) study only a looked at the effect of GTE consumption on 
a physiological marker (VO2max ) for endurance potential and did not truly test its effect 
on endurance performance in humans. However, just recently a study was published (16) 
that examined the relationship between GTE consumption and endurance performance. 
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The study used a 3-way crossover, randomized, placebo-controlled, double-blind, diet-
controlled research design. All participants, who were trained cyclists, received, in 
random order, 3 different treatments (placebo 270 mg, EGCG 270 mg, and placebo 270 
mg + caffeine 3 mg/kg) over a 6-d period and 1 hr before exercise testing. Exercise 
testing involved each participant completing 3 exercise trials consisting of 60 min of 
cycling at 60% VO2max immediately followed by a self-paced 40-km cycling time trial. 
This study did not find any effect of EGCG consumption on exercise endurance, or on fat 
oxidation.  
 While this was a well-controlled and well-designed study, it had some limitations. 
While EGCG appears to be the most active nutritional constituent of GT, it is not the only 
catechin present in GT that exerts physiological effects (13). Also, long-term 
consumption of GT is thought to have the most profound effect on an individual’s 
physiology. Therefore, six days of supplementation might not be a long enough duration 
to determine the potential of GT consumption to improve exercise endurance. In fact, in 
the studies that demonstrated improved endurance in mice consuming GTE, significant 
improvements were not measured until eight weeks of supplementation had been 
completed (13).      
Furthermore, the effects of GTE on the mice were dose-dependent, with the mice 
consuming the smaller amounts of GTE (= to a human consuming ~ 4 cups of GT/d) 
showing non-significant improvements in endurance (13). The mice that demonstrated 
significantly increased endurance compared to placebo mice consumed an amount of 
GTE that would be equivalent to a human consuming approximately 10 cups of GT per 
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day. The subjects in this human study only consumed the amount of EGCG found in ~ 2 
cups of GT a day. In short, the researchers might have found different results if they had 
used a whole GTE supplement rather than EGCG, and/or used a higher dose of catechins, 
and/or a longer supplementation period.  
In conclusion, several studies clearly demonstrate that consumption of GT can 
improve exercise endurance in mice (4, 13, 14) and increase whole body lipid utilization 
in mice and humans during exercise and at rest (1-5, 7, 8, 19-21, 37, 47). One study 
showed an improved VO2max in humans who consumed EGCG (15).  Together, these 
findings suggest that consumption of GT or GTE could result in improved endurance 
ability in humans. However, this hypothesis has only been tested once before (16). While 
that study failed to find a significant effect of EGCG on endurance, it had several 
limitations. Therefore, the objective of this study was to determine if the daily 
consumption of a higher dose decaffeinated GTE, for 4-5 weeks, could improve exercise 
endurance in humans, as measured by 2.5 mile running time trials conducted on an indoor 
track. 
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CHAPTER III 
METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
22 
Participants 
  
 In order to be eligible for the study, participants had to be aged 18-40 yrs, 
not have a history of liver problems or any other chronic illness such as ulcers, diabetes, 
gastro-intestinal problems, not be currently ill, and not be pregnant. Also, participants 
must have been performing aerobic exercise at least twice a week for 20-30 minutes at a 
fairly vigorous pace, had consumed green tea or green tea extract without any adverse 
effects, and not be a cigarette smoker, excessive drinker (more than 5 alcoholic drinks per 
day), or illegal drug user. Therefore, all participants were healthy, physically active 
undergraduate or graduate students, with one faculty member participating (see Table 1). 
All participants had previously signed medical waivers to engage in demanding physical 
activity at the Georgia State University (GSU) Recreation Center. The Institutional 
Review Board at GSU approved the experimental protocol (see Appendix A). 
 
Table 1: Participant characteristics 
Exclusion Criteria Inclusion Criteria 
History of chronic illness Age 18-40 (mean age: 23) 
Currently ill Currently perform vigorous aerobic 
exercise 2-3 x /wk 
Pregnant Signed medical waiver to exercise at GSU 
Recreation Center 
Smoker Prior consumption of GT with no side 
effects 
Heavy drinker or illegal drug user  
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Subjects were recruited using fliers posted at the GSU Recreation Center (see 
Appendix B); in-person recruiting at the Recreation Center indoor track; in-person 
recruiting at selected Health Science classes; and e-mails sent to all Division of Nutrition 
students (see Appendix C). The objective, methodology, and risks of the study were 
explained to each subject and written informed consent was obtained (see Appendix D). 
Sixteen subjects agreed to participate. 
 
Design 
 This study was designed as a randomized, placebo-controlled, double-blinded 
study. The participants were randomly and alternately divided into the A or B group in 
the order that they volunteered for the study. Participants were not informed whether they 
were receiving intervention (GTE) or placebo. The researcher was also blinded to which 
group was receiving which treatment.  
  
Run Trials 
Participants completed two running trials (RTs) separated by 4-5 weeks. Each run 
trial consisted of running 20 laps on the GSU Recreation Center indoor track (length: ~ 
1/8 of a mile) for a total of ~ 2.5 miles. Participants were instructed to give their best 
effort in completing the distance as fast as they could. Every 2-3 laps they were given an 
update on how many laps they had completed. Lap counts were monitored and recorded 
by using a list numbered 1-20 for each participant and crossing off the appropriate 
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number as each lap was completed. Times were recorded via an Ironman Timex stop-
watch, and were backed up by the Recreation Center track clock.  
RTs took place over several days, and 1-5 participants ran at the same time for 
each trial, with start times staggered by 30 sec to 2 min. During each RT, a few other 
runners not connected to the study were jogging on the track. While there was some 
concern that these other runners could interfere with the progress of the study 
participants, they did not to do so. In fact, these other joggers gave the runners who 
completed their trials alone some sense of “company” or “competition” similar to that 
which the runners who ran at the same time as other participants experienced. An equal 
number of participants (n=2) from each treatment group ran their RT’s alone, while the 
others ran at the same time as other participants.  
 
Intervention (GTE) and placebo treatments 
The GTE capsules were obtained from Food Science of Vermont (Essex Junction, 
VT). Each capsule contained a total of 450 mg of GT polyphenols, which included 350 
mg of EGCG , and also included a small amount of rice flour and vegetable cellulose (see 
Appendix E). Each capsule contained the amount of GT catechins and EGCG equivalent 
to about 2.5-3 cups of GT. Participants were instructed to consume 2 capsules/d, for a 
total of 900 mg polyphenols and 700 mg EGCG, roughly equivalent to about 5-6 cups of 
GT/d.   
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Placebo capsules were made using empty vegetable celluose capsules, equal in the 
size to the GT capsules (size “0”), that were obtained from Wonder Laboratories (White 
House, TN). The capsules were filled with organic Buckwheat and Teff flour purchased 
from the local farmer’s market. Capsules were filled in sanitary conditions using a 
capsule filling machine purchased from Wonder Laboratories (White House, TN).  
While the color of the GT and placebo capsules was not identical, neither one 
appeared green. Furthermore, participants were asked not to compare their capsules to 
those in the other group. Informal pretrial testing with individuals not participating in the 
study indicated that which capsules contained GTE or placebo could not be discerned. 
However, when asked to guess which treatment group they were in, the majority of 
participants were able to guess correctly (70% correct). None of them stated that they 
based their guess on the appearance of the capsules, but that they either guessed 
randomly or based on how they felt during the study. 
Placebo and GT capsules were placed into identical, unmarked white bottles set 
aside in their respective groups. A researcher not connected with this study randomly 
determined which treatments would be labeled group A and group B, and then labeled the 
bottles appropriately. The researcher recorded this information separately from the rest of 
the study data, such that the researcher conducting the study and the participants were 
blinded as to the identity of groups A and B. Bottles were distributed to participants upon 
completion of their first RT, with participant 1 in group A, participant 2 in group B, and 
alternating from there. Participants were instructed to take 2 capsules/d (one in the 
morning, one at night) with food. They were given enough capsules to allow them to 
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consume that amount for 4-5 wk’s. The initial study protocol planned for the 
supplementation period to last five weeks. However, due to time constraints, participants 
who volunteered late only took the supplement for 4 wks.  
 
Diet and exercise records and controls 
During the study period, participants were instructed not to change their diet from 
what they normally ate and to complete a 3-d food record on the USDA’s website, 
MyPyramidTracker. Participants were also instructed not to consume any supplements 
other than multi-vitamins or fish oil; limit coffee consumption to no more than one cup a 
day (or ~ 150- 200 mg of caffeine from other sources); and to consume no tea beverages 
at all during the study period. These instructions were given to ensure that participants 
did not consume any supplements, beverages, or food that contained tea catechins or 
similar polyphenols. Participants were asked to limit  caffeine consumption during the 
study because there is some evidence that, when consuming GT, high caffeine users 
demonstrate less of an increased fat oxidation effect than do lower caffeine users  (12, 
22). Lastly, participants were instructed to keep an exercise diary on their physical 
activity. 
Participants were instructed to record the amount and type of exercise they 
engaged in (if any) on the day before RT1 (baseline run trial) and to repeat that type and 
amount of activity on the day before RT2 (post-intervention run trial). They were also 
instructed to consume the same diet on the day of their two RT’s, and not to consume 
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coffee or any caffeine-containing beverages or foods within four hours of their RTs. 
Records were checked at the end of the study to determine compliance.  
 
Statistical analysis 
 Statistical analyses were conducted using independent (unpaired) t-tests (2-tailed) 
to compare between group (GTE and placebo) totals for calorie intake during the study, 
and endurance performance for RT1, RT2, and RT1-RT2 (endurance improvement). 
Paired t-tests were conducted to compare within group change for RT1-RT2. The level of 
statistical significance was set at P < 0.05. Statistical analyses were completed using the 
Statistical Package for Social Sciences (SPSS version 17.0). 
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CHAPTER IV 
RESULTS 
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Of the 16 participants that began the study, 14 completed it (GTE, n= 7; placebo, 
n= 7), which is an 88% completion rate. The two participants that dropped out did so for 
unknown reasons. These two participants that dropped out were two of only three 
participants who could not complete the 2.5 mile RT’s without walking part of the way.  
Whether or not the data of the 3rd participant who walked (participant #5, placebo 
group) should be included in the data analysis is unclear. Although participants were told 
that walking was allowed during the RT’s, this participant was the only one to compete 
the study that did so, and she walked the majority of the distance in both RT’s. 
Furthermore, she was one of only two participants to get slower from RT1 to RT2, and 
the only one to do so to a large degree: she ran RT2 7.35% slower than her RT1, while 
the other participant who did not improve in RT2 on her time from RT1 was only slower 
by 0.78%.  However, her percentage change from RT1 to RT2 was within three standard 
deviations (SD’s) of the mean change for all participants, thus putting her just within the 
acceptable statistical range. The mean percentage change for all participants was 2.26% ± 
SD 3.56%, with a range of -8.42%, 12.94%. Therefore, the decision was made to run two 
sets of analyses, one including participant #5, and one not. Analysis 1 contained data 
from all 14 participants, and Analysis 2 contained 13 participants, as it did not include the 
data from participant #5.  
 
Run Performance 
Data Analysis 1: 
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Between Group Comparison 
The mean times for the baseline run trial (RT1) were 1169 sec for the placebo 
group and 1256 sec for the GTE group. There was no significant difference between the 
groups at baseline (P = 0.49). The mean times for the post-intervention run trial (RT2) 
were 1151 sec for placebo, and 1228 sec for GTE, and again there were no significant 
difference between groups. The mean improvement in performance, from RT1 to RT2 for 
the placebo group was 18 sec, or 2.09%. The mean improvement in performance for the 
GTE group was 28 sec, or 2.43%.  For the major endpoint of the study, there was no 
significant difference between the endurance performance improvements of the 2 groups 
(P = 0.74) (see Table 2). 
 
TABLE 2: Between and Within Group Comparisons of Group Mean Run Times 
                       DATA ANALYSIS 1                               DATA ANALYSIS 2 
 PLA 
(n=7) 
GTE 
(n=7) 
P Value 
between groups 
PLA 
(n=6) 
GTE 
(n=7) 
P Value 
between groups 
RT1, sec 1169 1256 0.49 1101 1256 0.18 
RT2, sec 1151 1228 0.58 1060 1228 0.16 
RT1-RT2, sec 18 28 0.74 41 28 0.38 
P Value 
within group  
0.48 0.02*  0.02* 0.02*  
 
GTE= green tea extract group, PLA = placebo group; RT1= run trial 1 (baseline run 
trial), RT2 = run trial 2 (post-intervention run trial); RT1-RT2 = Improvement in 
performance from baseline trial to post-intervention trial. 
*P < 0.05, statistically significant 
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Within Group Comparison 
 The mean 18 sec improvement from RT1 to RT2 by the placebo group was not 
statistically significant (P = 0.48).  However, the mean improvement of 28 sec from RT1 
to RT2 by the GTE group was significant (P = 0.02) (see Table 2). 
 
Data Analysis 2: 
Between Group Comparison 
The mean times for the baseline run trial (RT1) were 1101 sec for placebo (n =6), 
and 1256 sec for the GTE (n=7). There was no significant difference between the groups 
at baseline (P = 0.18). The mean times for the post-intervention run trial (RT2) were 1060 
sec for placebo, and 1228 sec for GTE, and again there were no significant difference 
between groups (P = 0.16). The mean improvement in performance, from RT1 to RT2, 
for the placebo group was 41 sec, or 3.66%. The mean improvement in performance for 
the GTE group was 28 sec, or 2.43%.  There was no significant difference between the 
improvements of the two groups ( P = 0.38) (see Table 2). 
 
Within Group Comparison 
 The mean 41 sec improvement from RT1 to RT2 by the placebo group was 
statistically significant (P = 0.02).  The mean improvement of 28 sec from RT1 to RT2 
by the GTE group was also significant (P = 0.02) (see Table 2). 
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Diet 
 Diet information was incomplete. Ten of the fourteen participants (GTE, n=5; 
Placebo, n=5) recorded 3-d diet records on MyPyramidTracker. Based on the participant 
data recorded, the GT group consumed an average of 1942 calories per day during the 
study period, and the placebo group consumed an average of 1833.  There was no 
significance difference between the total calorie consumption of groups during the study 
(P = 0.32).  
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
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Consumption of GT, GTE, or EGCG has been shown to increase fat oxidation in 
mice and humans at rest and while exercising (1-3, 5, 13, 21, 22, 48), increase exercise 
endurance in mice (4, 13), and increase VO2max in humans (15). The only published study 
to directly measure the effect of consumption of GTE on endurance performance 
(measured with cycling time trials) in humans did not find significant results (16). Our 
study used a higher dose and longer period of GTE supplementation than did that study. 
Furthermore, we measured endurance performance via running (2.5 miles) rather than 
cycling time trials.  Our study also did not find a significant difference in endurance 
performance between groups consuming placebo and GTE. However, under our one data 
analysis we did find that the GTE group significantly improved their performance in the 
second RT compared to baseline, while the placebo group did not. Yet under the other 
data analysis, with one potential outlier excluded, both placebo and GTE groups 
significantly improved from baseline to RT2. Therefore, the results of our study taken as 
a whole do not demonstrate efficacy of GTE consumption to increase exercise endurance. 
 This study had some important strengths and findings. This was only the 
second study to directly test the hypothesis that GT consumption can improve exercise 
endurance in humans. The design of this study more closely resembled, in duration and in 
GTE amount and composition, the mouse studies conducted by Murase  et al. (4, 13), 
than did the other study (16) to test the effect of GTE on endurance performance. We 
found that moderately high GTE consumption (~900 mg polyphenols, 700 mg EGCG), 
for a moderately long period of time (4-5 weeks) results in virtually no reported side-
effects by human participants. The RTs were conducted on an indoor track, rather than a 
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treadmill, which is an exercise scenario more relevant to real-world activities and 
competitions. Lastly, this study measured actual endurance performance rather than a 
physiological marker of potential endurance (such as VO2max, or lactate threshold, etc). 
However, despite its strengths, this study had limitations that likely reduced our 
ability to find significant results. For instance, the sample size was smaller than 
anticipated. It was estimated that 35-40 of participants would be required to reach the 
desired statistical power, higher than the number of participants completing the study. 
Also, some aspects of the study could not be well controlled. While the intention of the 
study was to examine free-living humans without strict controls, time constraints and 
some lack of participant adherence to the study protocol resulted in more differences 
between individuals and possibly the two groups than anticipated. 
For example, participants ran on different days and under slightly different 
circumstances. Some ran at the same time as other participants, some separately, and 
some ran one trial with others, and the other trial separately. We planned to have 
participants run in a few large groups. In that case, even if they were not all running 
together, they would have had similar competitive, group experiences. However, this was 
not possible due to scheduling conflicts. Thus, the participants who ran together likely 
had a more competitive atmosphere than the ones who ran individually. While these 
discrepancies were approximately equal between treatment groups, in such a small 
sample size, they might have affected the outcome.  
Likewise, some participants did not do exactly the same type and amount of 
exercise before each of the two trials, as had been requested of them. For example, one 
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participant raced a half-marathon (13.1 miles) the day before the baseline trial, but only 
ran an 8 mile practice run the day before the second trial, with the result being that she 
was likely more rested for the second trial. Participation in the study required that 
participants had been performing “aerobic exercise at least twice a week for 20-30 
minutes at a fairly vigorous pace”, and they were expected to maintain that amount of 
exercise during the study. However, based on exercise logs provided by the participants, 
some did not meet that standard during the study period. In the studies that reported 
increased endurance in mice that consumed GTE, the mice exercised intensely two to 
three times a week, and in the case of one of the studies, that included once a week to 
exhaustion (4, 13).  
Catecholamines, such as norepinephrine, are released during exercise from 
sympathetic nerves, which stimulates fat breakdown and usage (4, 62). GT catechins 
have been shown to inhibit COMT, the enzyme that breaks down catecholamines (4). 
Therefore, GT consumption might have a more marked effect on increasing fat oxidation 
in individuals who regularly engaged in activities that stimulate the sympathetic nervous 
system and result in catecholamine release, such as exercise. In other words,  GT 
catechins may work synergistically with exercise to produce weight loss and increased fat 
oxidation, and possibly increase endurance (4, 16). In the absence of exercise or other 
catecholamine-stimulating activities, consumption of GT catechins might not have such a 
pronounced effect. In this study, some participants did not regularly exercise to the 
degree requested, and this might have limited the effects of GTE on endurance 
performance.  
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Another possible limitation of this study was amount of GTE consumed by 
participants. Participants were asked to consume a daily amount of GTE that contained 
900mg GT polyphenols, and included 700 mg EGCG, equal to ~ 5-6 cups of GT per day. 
While this is not considered a low amount in relation to other studies in humans, it is less 
than what was required to produce significantly increased endurance in mice. Those 
studies by Murase  et al. (4, 13) only showed significant effects of GTE on endurance in 
mice consuming an amount of GTE equivalent to a human consuming ~ 10 cups of GT 
per day. The mice consuming a lower amount (~ 3-4 cups of GT a day) also improved 
their endurance compared with control mice, but this difference was not statistically 
significant. Furthermore, while overall compliance with capsule intake in our study was 
fairly high (90%), some participants did miss doses, and this could have further diluted 
the effect of GT consumption on endurance.  
Another possible limitation was study length. The study period was only 4-5 
weeks. Based on results of the studies conducted by Murase et al. (4, 13) on mice, and in 
some weight loss studies conducted on humans, GTE supplementation appears to have a 
more significant effect on endurance and fat oxidation when consumed for a duration of 
8-12 weeks, which is two to three times the length of this study (1, 4, 11, 13, 16) .  
Further studies are needed which address the limitations of this study.  Future 
studies would benefit from a longer study duration (8-12 weeks), a slightly higher amount 
of GTE supplementation (equivalent to ~ 6-8 cups GT per day), and a larger sample size 
(~ n= 40). Other improvements could include having study participants complete 2-3 run 
trials at baseline and post-intervention to better control for individual variances, 
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increasing the distance of the run trials to 5-6 miles to more accurately reflect endurance 
performance, and having all participants take part simultaneously in the same run trials to 
better control for the effects of competition on run performance. Increased adherence to 
the study protocol, through emphasis on the importance of following the study protocol 
or use of incentives, would also be a key improvement.  
One method to accomplish these changes could be to invite members of a running 
team or exercise/nutrition clients of the researcher to participate. This would ensure that 
participants would have regular contact with the researcher, and their workouts would 
either be directed by or at least more easily monitored by him. This would allow for more 
control of differences in exercise regimens during the study period that could effect 
results. Lastly, the one could attempt to strictly control food intake during the study by 
contacting a prepared foods supplier to see if they would be interested in taking part in 
the study.  Under that scenario, participants could consume the prepared foods for two 
meals each day, and follow dietary guidelines for the 3rd meal, thus enabling strong diet 
control for the study.  
 
CONCLUSIONS 
While this study and the only published study (16) to measure the effects of GTE 
consumption on exercise endurance  in humans did not demonstrate significant results, 
both studies had many limitations, and there is still a considerable amount of rationale 
that suggests that GT consumption might have this effect (4, 13, 15, 16). This rationale is 
based on research that has shown that GT consumption increases both endurance and 
  
39 
physiological markers for endurance in mice, and physiological markers for endurance in 
humans. In fact, it is reported that a study that has just been conducted at the University 
of Glasgow on the effect of GT consumption on endurance performance is producing 
positive results (63); however, it is not published at this time and it remains to be seen if 
results will truly be statistically significant. Therefore, while the promise that GT has 
shown for many years as a potential ergogenic aid still exists, it remains to be realized at 
this time.  
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APPENDIX A 
IRB APPROVAL OF PROTOCOL E-MAILS 
 
From: svogtner1@gsu.edu [svogtner1@gsu.edu] 
Sent: Friday, December 18, 2009 12:48 PM 
To: Eric Green; vganji@gsu.edu 
Subject: Protocol Approved 
 
The Protocol you submitted has been approved by the IRB. 
 
Protocol Title: The Effect of Green Tea Extract on Exercise Endurance in Humans 
PI: Ganji, Vijay 
 Protocol Number: H10144 
 
 To view this Protocol, please go to this page 
https://irbwise.gsu.edu///sub/submissionview.form?submissionId=14410 
 
------------------------------------------------------------------------------- 
From: svogtner1@gsu.edu [svogtner1@gsu.edu] 
Sent: Friday, December 18, 2009 12:45 PM 
To: Eric Green; vganji@gsu.edu 
Subject: Approved Consent Forms Stamped 
 
This is an automated message from IRBWISE.  Consent Forms for Protocol, Protocol 
H10144, have been approved and stamped. 
 
PLEASE PRINT AND USE ONLY THE STAMPED VERSION FOR ENROLLING 
PARTICIPANTS.  YOU CAN ALSO ACCESS YOUR APPROVED DOCUMENTS ON IRBWISE. 
 
Download Stamped Consent Forms at 
https://irbwise.gsu.edu///associateddocuments.srv?submissionId=14410 
---------------------------------------------------------------------------------- 
 
INSTITUTIONAL REVIEW BOARD 
 
 Mail: P.O. Box 3999  In Person: Alumni Hall 
  Atlanta, Georgia  30302-3999  30 Courtland St, Suite 217 
 Phone: 404/413-3500 
 Fax:  404/413-3504 
December 18, 2009 
 
Principal Investigator: Ganji, Vijay  
Student PI: Eric Green 
Protocol Department: Nutrition  
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Protocol Title: The Effect of Green Tea Extract on Exercise Endurance in Humans 
Submission Type: Protocol H10144 
Review Type: Expedited Review 
Approval Date: December 18, 2009 
Expiration Date: December 17, 2010 
 
The Georgia State University Institutional Review Board (IRB) reviewed and approved the 
above referenced study and enclosed Informed Consent Document(s) in accordance with the 
Department of Health and Human Services.  The approval period is listed above. 
 
Federal regulations require researchers to follow specific procedures in a timely manner.  For the 
protection of all concerned, the IRB calls your attention to the following obligations that you 
have as Principal Investigator of this study. 
 
1. When the study is completed, a Study Closure Report must be submitted to the 
IRB.   
 
2. For any research that is conducted beyond the one-year approval period, you must 
submit a Renewal Application 30 days prior to the approval period expiration.  As a 
courtesy, an email reminder is sent to the Principal Investigator approximately two 
months prior to the expiration of the study.  However, failure to receive an email 
reminder does not negate your responsibility to submit a Renewal Application.  In 
addition, failure to return the Renewal Application by its due date must result in an 
automatic termination of this study.  Reinstatement can only be granted following 
resubmission of the study to the IRB. 
 
3. Any adverse event or problem occurring as a result of participation in this study 
must be reported immediately to the IRB using the Adverse Event Form. 
 
4. Principal investigators are responsible for ensuring that informed consent is obtained and 
that no human subject will be involved in the research prior to obtaining informed 
consent.  Ensure that each person giving consent is provided with a copy of the Informed 
Consent Form (ICF).  The ICF used must be the one reviewed and approved by the IRB; 
the approval dates of the IRB review are stamped on each page of the ICF.  Copy and use 
the stamped ICF for the coming year.  Maintain a single copy of the approved ICF in 
your files for this study.  However, a waiver to obtain informed consent may be granted 
by the IRB as outlined in 45CFR46.116(d). 
 
All of the above referenced forms are available online at https://irbwise.gsu.edu.  Please do not 
hesitate to contact Susan Vogtner in the Office of Research Integrity (404-413-3500) if you have 
any questions or concerns. 
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Sincerely, 
 
 
Susan Laury, IRB Chair 
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VOLUNTEERS NEEDED 
FOR GREEN TEA/Exercise RESEARCH 
STUDY! 
                                
QuickTime™ and a
TIFF (Uncompressed) decompressor
are needed to see this picture.
             
QuickTime™ and a
TIFF (Uncompressed) decompressor
are needed to see this picture.
 
Be a part of a Georgia State University Division of Nutrition research study 
Research has shown that consumption of green tea can enhance fat burning in mice and 
humans, and increase exercise endurance in mice. Therefore, it is hypothesized that 
green tea could enhance exercise endurance in humans, and it is this hypothesis that will 
be tested. 
STUDY DETAILS: 
• Study will last for 5 weeks 
• Participants will consume capsules of either green tea extract or 
placebo (made of vegetable cellulose filled with a small amount of 
rice flour) each day 
• Participants will take part in 2 run/walk trials (one at the beginning of 
the study, one at the conclusion). Each trial will consist of “running” 3.1 
miles (5k) as quickly as one can (walking is allowed if one is unable to run 
the whole way).  
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You are Eligible to Enroll if You: 
• Are aged 18-40 
• Currently perform aerobic exercise at least twice a week for 20-30 minutes 
• Have consumed green tea or green tea extract before without any adverse effects 
• Do not have a history of liver problems, ulcers, diabetes, GI problems (Crohn, Celiac, 
IBT, etc), and are not pregnant, do not smoke, and do not regularly consume more 
than 5 alcohol drinks per day 
 
If interested, or you have any questions, please contact Eric Green at 
egreen19@student.gsu.edu, or Dr Vijay Ganji at vganji@gsu.edu .  Thank you for your 
consideration.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX C 
RECRUITMENT E-MAIL TO GSU DIVISION OF NUTRITION STUDENTS 
 
 
Hi all, 
  
53 
 
My name is Eric Green, and under the advisement of Dr. Ganji, I am completing my 
master's thesis project. My project is conducting a research study on "The Effect of Green 
Tea on Exercise Endurance in Humans." In order to carry this out, I need volunteers from 
GSU to be participants in the study. It is a quite simple design, and would not involve a 
lot of your time (and should be fun too).  
 
The details of the study are on the two documents I have attached. Please read the 
documents attached and e-mail me back if you are interested or have any questions 
regarding the study. If you are interested, I will really appreciate your participation! (and 
if you know anyone else at GSU that might be interested, please let them know about the 
study) 
 
Lastly, if anyone is interested in assisting me in timing some of the study volunteers at 
the recreation center indoor track, that would also be very helpful. You can also contact 
me if you'd like to do that.  
 
The study will begin in a few weeks 
 
Thank you for your time and consideration. 
 
Eric 
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Consent Form Approved by Georgia State University IRB February 01, 2010 - December 17, 2010 
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Georgia State University 
Department of Nutrition 
Informed Consent 
Title: Effect of Green Tea Extract on Endurance Ability in 
Humans 
Principal Investigator: Dr Vijay Ganji, Ph.D., R.D. 
Student, P.I. Eric Green, Masters in Nutrition Candidate 
I. Pu rpose: 
You are being invited to take part in a research study. The purpose of the study is to 
investigate the effect of green tea extract on exercise endurance ability (as measured by 5 
kilometer/3.1 mile run/walk time). In order to participate, you must meet the following 
criteria: 
 You are aged 18-40 
 You currently perform aerobic exercise (any one or combination of the following: 
brisk walking, jogging/running, swimming, bicycling, rollerblading, stairmaster, 
elliptical machine, aerobics class, etc) at least twice a week for 20-30 minutes, at a 
fairly vigorous pace. 
 You have consumed green tea or green tea extract before without any adverse 
effects 
 You do not have a history of liver problems, or any other chronic illness (ulcers, 
diabetes, GI problems [Crohn, Celiac, IBT, etc], etc ) 
 You are not currently pregnant 
 You are not currently ill 
 You do not currently smoke cigarettes, drink to excess (more than 5 alcoholic 
drinks per day), or use illegal drugs 
The study will last 5 weeks. Approximately 40 participants will be recruited to take part 
in 
the study. Participation will include the following activities: 
 Two 5-kilometer (5k, 3.1 miles) run/walk timed trials: approximately 30 minutes 
Consent Form Approved by Georgia State University IRB February 01, 2010 - December 17, 2010 
each. 
 Daily recording (for 5 weeks) of exercise performed the day: 5 minutes/day 
 Record 3 days of food intake (each day’s record should take about 20-30 minutes. 
Only 3 days are needed, you are not doing this every day) 
 Twice-daily consumption of green tea extract or placebo pill: 1 minute/day. 
II . Procedures : 
The study will take place during winter/spring 2009 (exact dates to be determined 
soon). Participation will involve the following: 
 At the beginning and end of the study, you will be asked to participate in a 5k 
run/walk trial (you do not need to run the whole way if you are unable to. You 
must simply complete the 3.1 miles as quickly as you can). 
 Eric Green will be recording the times for the trials, and will likely be assisted by 
other graduate students from the GSU division of nutrition. The trials will be 
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conducted on the GSU indoor track. 
 Each day during the study, you will be asked to take a capsule (either green tea 
extract or inert placebo) with breakfast and dinner, and write down how much you 
exercised that day. Taking the capsule should take no more than 30 seconds, and the 
recording of your exercise for the day should take you no more than 10 minutes 
total to complete each day. 
 All participants are eligible to receive free nutrition counseling during this study if 
they desire it. Simply contact Eric Green for details of this benefit 
(egreen19@student.gsu.edu). 
III. Risks: 
In this study, you should not experience any more risks than you would in a 
normal day of life. 
However, in extremely rare cases, a few individuals have experienced liver problems that 
were believed to be due to consumption of green tea or green tea extract. This could have 
Consent Form Approved by Georgia State University IRB February 01, 2010 - December 17, 2010 
been due to unknown contaminants in the tea or extract, individuals having an extremely 
rare genetic mutation that made them not able to tolerate green tea, or other unknown 
possibilities. Although any adverse reaction to the amount of green tea extract being used 
in this study is extremely unlikely, we are being as safe as possible by only accepting 
participants who have met certain criteria (listed above). To ensure participant safety, the 
following safety measures will be used: 
* The green tea extract used in the study will be one that has been independently verified 
to contain no contaminants or impurities, and to contain the amount of green tea claimed 
on the bottle. 
* The amount of daily green tea extract consumed by the subjects will be equal to 
approximately 5 cups of green tea. This is a moderate amount that has been consumed 
safely by millions of people all over the world. It is also equal to 1/4 the amount found to 
cause no adverse effects in humans in recent trials, and is 400 times less than the no 
observable adverse effects limit (NOAEL) found in mice (i.e., 400 x the amount of green 
tea extract that you will be consuming, per pound of body weight, was consumed by mice 
with no adverse health effects found in the mice) 
* The participants will be instructed to consume the supplement twice a day with food 
(since food consumption slows absorption). 
* Only those individuals who have consumed green tea before, and who have not 
experienced any discomfort when consuming it, will be included in the study. 
* Those individuals with a history of liver problems will be excluded from the study. 
* All subjects will be instructed to immediately stop taking the capsules if they 
experience any minor discomforts (e.g., dizziness, or any Gastro-Intestinal(GI) 
disturbances. GI disturbances commonly include stomach pain, heartburn, diarrhea, 
constipation, nausea and vomiting). 
* All subjects will be instructed to immediately stop taking the capsules and contact their 
doctor if they experience any of the following symptoms which could indicate a liver 
disorder: abdominal pain or jaundice (symptoms of jaundice include a yellowing of skin 
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or the whites of the eyes, red, orange, or dark urine, and severe lethargy). 
Again, if you participate in this study, you should not experience any more risks 
than 
Consent Form Approved by Georgia State University IRB February 01, 2010 - December 17, 2010 
you would in a normal day of life. However, the above safety measures are being put 
in place in order to ensure participant safety to the highest degree possible. 
IV. Benefits: 
Participation in this study may benefit you personally. For instance, by participating in 
the 
study you may be motivated to be more active since you know that you will be taking 
part 
in two 5k timed trials. Furthermore, even short term green tea consumption has been 
shown in clinical trials to reduce body fat and improve markers of cardiovascular health 
(e.g., decrease blood pressure, LDL cholesterol, oxidative stress, and a marker of chronic 
inflammation). However, there is no guarantee that you will experience these benefits 
during this study. Also, you may be benefiting society by helping to determine if green 
tea 
can improve exercise endurance. Such knowledge could help people become more active 
and lead healthier lives. 
V. Voluntary Participation and Withdrawal: 
Participation in research is voluntary. You do not have to be in this study. If you 
decide to be in the study and change your mind, you have the right to drop out at any 
time. Whatever you decide, you will not lose any benefits to which you are otherwise 
entitled. 
VI. Confidentiality: 
We will keep your records private to the extent allowed by law. The only private 
information we will be receiving from you is your name and e-mail address. Dr Vijay 
Ganji, Ph.D., R.D., from the Division of Nutrition, will have access to the information 
you provide. Information may also be shared with those who make sure the study is done 
correctly (GSU Institutional Review Board, the Office for Human Research Protection 
(OHRP) and/or the Food and Drug Administration (FDA)). We will use your initials 
rather than your name on study records. The information you provide will be stored on 
password and firewall-protected computers. Your name and other identifying information 
Consent Form Approved by Georgia State University IRB February 01, 2010 - December 17, 2010 
will not appear when we present this study or publish its results. The findings will be 
summarized and reported in group form. You will not be identified personally. 
VII. Contact Persons: 
Contact Dr Vijay Ganji (at (404) 413-1236 or vganji@gsu.edu ), and/or Eric Green (at 
(404) 
408-9779 or egreen19@student.gsu.edu ) if you have any questions about this study. If 
you 
have questions or concerns about your rights as a participant in this research study, you 
may 
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contact Susan Vogtner in the Office of Research Integrity at 404-413-3513 or 
svogtner1@gsu.edu. 
VIII. Copy of Consent Form to Subject: 
We will give you a copy of this consent form to keep. 
If you are willing to volunteer for this research, please sign below. 
____________________________________________ _________________ 
Participant Date 
_____________________________________________ _________________ 
Principal Investigator or Researcher Obtaining Consent Date 
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APPENDIX F 
PARTICIAPANT RAW TIME DATA 
 
PARTICIPANT GROUP RT1 RT2 RT1-RT2 % IMPROVEMENT 
1 GTE 1122 1099 23 2.05% 
2 PLA 1156 1140 16 1.38% 
3 PLA 1579 1695 -116 -7.35% 
4 GTE 1557 1518 39 2.50% 
5 PLA 1344 1257 87 6.47% 
6 GTE 1290 1300 -10 -0.78% 
7 PLA 963 930 33 3.43% 
8 GTE 1238 1212 26 2.10% 
9 GTE 974 914 60 6.16% 
10 PLA 1010 1004 6 0.59% 
11 PLA 1139 1096 43 3.78% 
12 GTE 1053 1008 45 4.27% 
13 PLA 995 932 63 6.33% 
14 GTE 1557 1546 11 0.71% 
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APPENDIX G 
DATA ANALYSIS 
 
DATA ANALYSIS 1 
 
Independent T-Test 
 
 
 
Independent Samples Test 
  t-test for Equality of Means 
   
  
Sig. (2-tailed) Mean Difference 
Std. Error 
Difference 
Equal variances assumed .490 -86.42857 121.41591 RT1 
Equal variances not assumed .490 -86.42857 121.41591 
Equal variances assumed .580 -77.57143 136.54134 RT2 
Equal variances not assumed .581 -77.57143 136.54134 
Equal variances assumed .742 8.85714 26.24531 Difference 
Equal variances not assumed .745 8.85714 26.24531 
 
 
Paired T-Test for PLACEBO GROUP 
Paired Samples Statistics 
  Mean N Std. Deviation Std. Error Mean 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
PLA 7 1169.4286 222.78005 84.20295 RT1 
GTE 7 1255.8571 231.43424 87.47392 
PLA 7 1150.5714 267.30997 101.03367 RT2 
GTE 7 1228.1429 243.00235 91.84626 
PLA 7 -18.8571 65.49155 24.75348 Difference 
GTE 7 -27.7143 23.07751 8.72248 
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RT1 1169.4286 7 222.78005 84.20295 Pair 1 
RT2 1150.5714 7 267.30997 101.03367 
 
 
Paired Samples Correlations 
  N Correlation Sig. 
Pair 1 RT1 & RT2 7 .981 .000 
 
 
Paired Samples Test 
  Paired Differences 
   
  Mean Std. Deviation Std. Error Mean 
Pair 1 RT1 - RT2 18.85714 65.49155 24.75348 
 
Paired Samples Test 
  Paired Differences  
  95% Confidence Interval of the 
Difference  
  Lower Upper t df Sig. (2-tailed) 
Pair 1 RT1 - RT2 -41.71244 79.42672 .762 6 .475 
 
 
Paired T-Test for GREEN TEA EXTRACT GROUP 
 
Paired Samples Statistics 
  Mean N Std. Deviation Std. Error Mean 
RT1 1255.8571 7 231.43424 87.47392 Pair 1 
RT2 1228.1429 7 243.00235 91.84626 
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Paired Samples Correlations 
  N Correlation Sig. 
Pair 1 RT1 & RT2 7 .996 .000 
 
 
Paired Samples Test 
  Paired Differences 
   
  Mean Std. Deviation Std. Error Mean 
Pair 1 RT1 - RT2 27.71429 23.07751 8.72248 
 
Paired Samples Test 
  Paired Differences  
  95% Confidence Interval of the 
Difference  
  Lower Upper t df Sig. (2-tailed) 
Pair 1 RT1 - RT2 6.37115 49.05742 3.177 6 .019 
 
 
 
DATA ANALYSIS 2 
Independent T-Test 
 
 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
PLA 6 1101.1667 142.88375 58.33205 RT1 
GTE 7 1255.8571 231.43424 87.47392 
RT2 PLA 6 1059.8333 128.78263 52.57529 
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GTE 7 1228.1429 243.00235 91.84626 
PLA 6 -41.3333 30.05772 12.27101 Difference 
GTE 7 -27.7143 23.07751 8.72248 
 
 
Independent Samples Test 
  Levene's Test for Equality of 
Variances t-test for Equality of Means 
    
  F Sig. t df 
Equal variances assumed 1.489 .248 -1.417 11 RT1 
Equal variances not assumed   -1.471 10.121 
Equal variances assumed 2.650 .132 -1.517 11 RT2 
Equal variances not assumed   -1.590 9.369 
Equal variances assumed .462 .511 -.924 11 Difference 
Equal variances not assumed   -.905 9.342 
 
Independent Samples Test 
  t-test for Equality of Means 
   
  
Sig. (2-tailed) Mean Difference 
Std. Error 
Difference 
Equal variances assumed .184 -154.69048 109.15700 RT1 
Equal variances not assumed .172 -154.69048 105.13950 
Equal variances assumed .157 -168.30952 110.91838 RT2 
Equal variances not assumed .145 -168.30952 105.82956 
Equal variances assumed .375 -13.61905 14.73179 Difference 
Equal variances not assumed .388 -13.61905 15.05521 
 
Independent Samples Test 
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  t-test for Equality of Means 
  95% Confidence Interval of the 
Difference 
  Lower Upper 
Equal variances assumed -394.94342 85.56246 RT1 
Equal variances not assumed -388.57663 79.19568 
Equal variances assumed -412.43924 75.82019 RT2 
Equal variances not assumed -406.28248 69.66343 
Equal variances assumed -46.04351 18.80541 Difference 
Equal variances not assumed -47.48734 20.24925 
 
 
Paired T-Test for PLACEBO GROUP 
 
Paired Samples Statistics 
  Mean N Std. Deviation Std. Error Mean 
RT1 1101.1667 6 142.88375 58.33205 Pair 1 
RT2 1059.8333 6 128.78263 52.57529 
 
 
Paired Samples Correlations 
  N Correlation Sig. 
Pair 1 RT1 & RT2 6 .981 .001 
 
 
Paired Samples Test 
  Paired Differences 
   
  Mean Std. Deviation Std. Error Mean 
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Paired Samples Test 
  Paired Differences 
   
  Mean Std. Deviation Std. Error Mean 
Pair 1 RT1 - RT2 41.33333 30.05772 12.27101 
 
Paired Samples Test 
  Paired Differences  
  95% Confidence Interval of the 
Difference  
  Lower Upper t df Sig. (2-tailed) 
Pair 1 RT1 - RT2 9.78969 72.87698 3.368 5 .020 
 
 
USE ALL. COMPUTE filter_$=(Group = 2). VARIABLE LABEL filter_$ 'Group = 2 
(FILTER)'. VALUE LABELS filter_$ 0 'Not Selected' 1 'Selected'. FORMAT filter_$ 
(f1.0). FILTER BY filter_$. EXECUTE. T-TEST PAIRS=RT1 WITH RT2 (PAIRED)   
/CRITERIA=CI(.9500)   /MISSING=ANALYSIS. 
 
Paired T-Test for GTE GROUP 
 
 
Notes 
Output Created 26-Apr-2010 11:10:16  
Comments  
Active Dataset DataSet0 
Filter Group = 2 (FILTER) 
Weight <none> 
Split File <none> 
Input 
N of Rows in Working Data 
File 
7 
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Definition of Missing User defined missing values are treated 
as missing. 
Missing Value Handling 
Cases Used Statistics for each analysis are based on 
the cases with no missing or out-of-
range data for any variable in the 
analysis. 
 Syntax T-TEST PAIRS=RT1 WITH RT2 
(PAIRED) 
  /CRITERIA=CI(.9500) 
  /MISSING=ANALYSIS. 
 
Processor Time 0:00:00.016 Resources 
Elapsed Time 0:00:00.015 
 
 
[DataSet0]  
 
 
Paired Samples Statistics 
  Mean N Std. Deviation Std. Error Mean 
RT1 1255.8571 7 231.43424 87.47392 Pair 1 
RT2 1228.1429 7 243.00235 91.84626 
 
 
Paired Samples Correlations 
  N Correlation Sig. 
Pair 1 RT1 & RT2 7 .996 .000 
 
 
Paired Samples Test 
  Paired Differences 
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  Mean Std. Deviation Std. Error Mean 
Pair 1 RT1 - RT2 27.71429 23.07751 8.72248 
 
Paired Samples Test 
  Paired Differences  
  95% Confidence Interval of the 
Difference  
  Lower Upper t df Sig. (2-tailed) 
Pair 1 RT1 - RT2 6.37115 49.05742 3.177 6 .019 
 
 
 
 
 
